Table 12.
Subgroup | Clinical presentation | |||
---|---|---|---|---|
Disappearance of Perifocal Oedema, Days | Disappearance of Perifocal Oedema, Days | Disappearance of Perifocal Oedema, Days | Disappearance of Perifocal Oedema, Days | |
Placebo | 9.4 ± 0.24 | 10.4 ± 0.24 | 10.6 ± 0.24 | 11.2 ± 0.2 |
Control | 6.71 ± 0.18 * | 7.71 ± 0.18 * | 7.71 ± 0.18 * | 7.86 ± 0.26 * |
Resveratrol | 7 ± 0 * | 8 ± 0 * | 8 ± 0 * | 8.14 ± 0.14 * |
Dihydroquercetin | 5.29 ± 0.18 *,# | 8.29 ± 0.18 *,# | 8.43 ± 0.2 *,# | 8.57 ± 0.2 * |
Dihydromyricetin | 7.14 ± 0.14 * | 8.14 ± 0.14 * | 8.29 ± 0.18 *,# | 8.43 ± 0.2 * |
*—p < 0.05 if being compared to the placebo group, #—p < 0.05 if being compared to the control group.